Atypical Hemolytic Uremic Syndrome Associated with BNT162b2 mRNA COVID-19 Vaccine in a Kidney Transplant Recipient: A Case Report and Literature Review

被引:0
作者
Pattonieri, Eleonora Francesca [1 ]
Gregorini, Marilena [1 ,2 ]
Grignano, Maria Antonietta [1 ]
Islami, Tefik [1 ]
D'Ambrosio, Gioacchino [3 ,4 ]
Ardissino, Gianluigi [5 ]
Rampino, Teresa [1 ,2 ]
机构
[1] Fdn IRCCS Policlin San Matteo, Unit Nephrol Dialysis & Transplants, I-27100 Pavia, Italy
[2] Univ Pavia, Dept Internal Med & Therapeut, I-27100 Pavia, Italy
[3] Univ Pavia, Dept Mol Med, Anat Pathol Unit, I-27100 Pavia, Italy
[4] Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy
[5] Fdn IRCCS CaGranda Osped Maggiore Policlin, Ctr HUS Prevent Control & Management, I-20162 Milan, Italy
关键词
BNT162b2; COVID-19; vaccination; hemolytic uremic syndrome; acute kidney injury; kidney transplant;
D O I
10.3390/idr17010014
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Case Report: We report a case of a 37-year-old female with kidney transplant, who was admitted at our hospital due to worsening renal function, nephrotic proteinuria, and anemia developed 21 days after the second dose of BNT162b2 COVID-19 vaccine (Pfizer-BioNTech). Laboratory tests revealed hemolytic anemia, thrombocytopenia, and acute kidney injury. Given the clinical picture of Thrombotic Micro-angiopathy (TMA) and severe renal impairment, plasma exchange (PEX) and dialysis were immediately started. Laboratory workup showed low C3 and C4 levels, normal activity of ADAMTS13, and the absence of anti-factor H antibodies. Molecular biology investigations revealed a heterozygous variant in exon 22 (SCR20) of the CFH gene (c.3628C>T; p.Arg1210Cys) described as an atypical Hemolytic Uremic Syndrome (aHUS) causative mutation. Our patient completed two sessions of PEX followed by eculizumab treatment with hematological improvement but no recovery of renal function. This is the first reported case of aHUS triggered by SARS-CoV-2 vaccination in a kidney transplant patient without recovery of renal function. Conclusion: Although rare, clinicians should be aware of possible nephrological complications that may appear after vaccination.
引用
收藏
页数:10
相关论文
共 41 条
[1]   Complement-Mediated Thrombotic Microangiopathy Related to COVID-19 or SARS-CoV-2 Vaccination [J].
Aigner, Christof ;
Gaggl, Martina ;
Schmidt, Sophie ;
Kain, Renate ;
Kozakowski, Nicolas ;
Oszwald, Andre ;
Prohaszka, Zoltan ;
Sunder-Plassmann, Raute ;
Schmidt, Alice ;
Sunder-Plassmann, Gere .
KIDNEY INTERNATIONAL REPORTS, 2023, 8 (08) :1506-1513
[2]  
Aku Thelma Alalbila, 2023, Niger Med J, V64, P846, DOI 10.60787/nmj-64-6-343
[3]  
Asti AL, 2022, NEW MICROBIOL, V45, P213
[4]   Development of mRNA nano-vaccines for COVID-19 prevention and its biochemical interactions with various disease conditions and age groups [J].
Baig, Mirza Muhammad Faran Ashraf ;
Wong, Lok Yin ;
Wu, Hongkai .
JOURNAL OF DRUG TARGETING, 2024, 32 (01) :21-32
[5]   COVID-19 vaccination and Atypical hemolytic uremic syndrome [J].
Bouwmeester, Romy N. ;
Bormans, Esther M. G. ;
Duineveld, Caroline ;
van Zuilen, Arjan D. ;
van de Logt, Anne-Els ;
Wetzels, Jack F. M. ;
van de Kar, Nicole C. A. J. .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[6]   Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients [J].
Cassaniti, Irene ;
Gregorini, Marilena ;
Bergami, Federica ;
Arena, Francesca ;
Sammartino, Jose Camilla ;
Percivalle, Elena ;
Soleymaninejadian, Ehsan ;
Abelli, Massimo ;
Ticozzelli, Elena ;
Nocco, Angela ;
Minero, Francesca ;
Pattonieri, Eleonora Francesca ;
Lilleri, Daniele ;
Rampino, Teresa ;
Baldanti, Fausto .
VACCINES, 2022, 10 (06)
[7]   Immune Response to BNT162b2 in Solid Organ Transplant Recipients: Negative Impact of Mycophenolate and High Responsiveness of SARS-CoV-2 Recovered Subjects against Delta Variant [J].
Cassaniti, Irene ;
Bergami, Federica ;
Arena, Francesca ;
Sammartino, Jose Camilla ;
Ferrari, Alessandro ;
Zavaglio, Federica ;
Curti, Irene ;
Percivalle, Elena ;
Meloni, Federica ;
Pandolfi, Laura ;
Pellegrini, Carlo ;
Turco, Annalisa ;
Seminari, Elena ;
Pattonieri, Eleonora Francesca ;
Gregorini, Marilena ;
Rampino, Teresa ;
Sarasini, Antonella ;
Lilleri, Daniele ;
Baldanti, Fausto .
MICROORGANISMS, 2021, 9 (12)
[8]   Eculizumab in secondary atypical haemolytic uraemic syndrome [J].
Cavero, Teresa ;
Rabasco, Cristina ;
Lopez, Antia ;
Roman, Elena ;
Avila, Ana ;
Sevillano, Angel ;
Huerta, Ana ;
Rojas-Rivera, Jorge ;
Fuentes, Carolina ;
Blasco, Miquel ;
Jarque, Ana ;
Garcia, Alba ;
Mendizabal, Santiago ;
Gavela, Eva ;
Macia, Manuel ;
Quintana, Luis F. ;
Maria Romera, Ana ;
Borrego, Josefa ;
Arjona, Emi ;
Espinosa, Mario ;
Portoles, Jose ;
Gracia-Iguacel, Carolina ;
Gonzalez-Parra, Emilio ;
Aljama, Pedro ;
Morales, Enrique ;
Cao, Mercedes ;
Rodriguez de Cordoba, Santiago ;
Praga, Manuel .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (03) :466-474
[9]   Acute kidney disease following COVID-19 vaccination: a single-center retrospective study [J].
Chen, Chien-Chou ;
Yang, Sung-Sen ;
Hsu, Yu-Juei ;
Sung, Chih-Chien ;
Chu, Pauling ;
Wu, Chia-Chao ;
Hsu, Shun-Neng ;
Wang, Han-En ;
Lee, Ding-Jie ;
Lin, Shih-Hua .
FRONTIERS IN MEDICINE, 2023, 10
[10]   Immune responses and safety of COVID-19 vaccination in atypical hemolytic uremic syndrome patients in Taiwan [J].
Chen, I-Ru ;
Wang, Guei-Jane ;
Hsueh, Po-Ren ;
Chou, Chia-Hui ;
Jeng, Long-Bin ;
Lin, Hui-Ju ;
Liao, Huang-Jiun ;
Lai, Ping-Chin ;
Chang, Jan-Gowth ;
Huang, Chiu-Ching .
VACCINE, 2023, 41 (41) :5940-5945